Yang, C., Li, Q., Wu, Y. (2025). Azacitidine and luspatercept metronomic therapy for intermediate- to high-risk myelodysplastic syndrome: A prospective single-center phase II clinical trial. Blood. https://doi.org/10.1182/blood-2025-5625